mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.05 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.06 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.06 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.06 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.06 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.06 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.06 |
mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.07 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.07 |